cleaning roducts ave eco e art and arcel o a consu er’s life. Consumer awareness is also growing every year, which is why manufacturers are focusing on elevating the quality of cleaning products with the best possible environmental conditions. Today's consumer is not just concerned about maintaining hygiene or cleanliness at a personal level but is also keen on reducing the chances of infections in his/her surroundings. So, to fulfill the hygiene needs at home as well as at commercial places, different ingredients are used in cleaning products.

Laboratory glassware stands as a cornerstone of scientific research, experimentation, and analysis. Its crucial role in maintaining precision, accuracy, and reliability within diverse industries highlights its significance in advancing knowledge and technological progress. The laboratory glassware market, driven by an amalgamation of scientific advances, evolving research needs, and technological innovation, is a vital enabler of breakthroughs and discoveries across various sectors.

Biometric POS terminals comprise point-of-sale (POS) devices that use biometrics-based data like fingerprints, retina scans, or even facial recognition to authenticate the identity of a customer or employee. These terminals replace PINs or passwords to verify the identity of the individual. Biometric POS terminals are often used to prevent fraud and theft or in key industries where security is critical. The retail, medical and healthcare, food service (restaurants), financial, logistics, government, and entertainment industries are some of the major end-users of biometric POS terminals.

经过全球产业分工，印度和中国基于各自比较优势成为世界主要原料药供应 国，印度仿制药在全球崛起既有历史机遇亦是产业升级的结果。从投资回报 来看，大部分印度制药股票走出长牛趋势，印度制药 Nifty Pharma 指数在 2001.01~2024.11 期间总回报 2406%，二十四年的年化收益率 14.41%，而 不少龙头企业的市场表现更为亮眼，如 Sun Pharma 在 2001.01~2024.11 期 间，股价上涨 146 倍，总回报 17351%(含股利)，二十四年的年化收益率 高达 24.08%，远跑赢 Nifty Pharma 和印度大盘 Sensex 指数。

伴随中国居民对于慢病重疾管理意识的提升，加之炎症、自身免疫性疾病、呼吸系统疾病和肿瘤等疾病负担持续上行，本土市场对于甾体中间体原料药的需求 不断上涨，由此引发政策重点关注激素类药物的绿色生产和用药安全问题。本土科研端以临床诊疗需求为抓手持续发力，运动医学理念的普及和抗衰老意识的 增强促使科研机构相继布局对于雄激素的研发探索，为满足药品生产需求，以睾酮为代表的雄激素中间体研究成果增速显著。同时优质的抗炎和免疫系统调节 作用以及重大公共卫生事件的诊疗需求共同驱动皮质激素原料药和中间体的研发生产增加，坚实的科研成果支撑中国逐步成为全球甾体药物中间体和原料药的 主要产地，本土厂商全球影响力提升指日可待。

The global synthetic biology market covers companies that are engaged in creating new biological parts, devices, and systems or redesigning existing systems using synthetic biology tools and technologies. The tools used in synthetic biology include oligonucleotides, enzymes, and synthetic cells, and the technologies applied include gene synthesis and bioinformatics.

Blood culture tests are diagnosis procedures that help to detect the presence of fungi and bacteria in the bloodstream. They are simple yet essential clinical tests that help identify and treat several infections. They offer valuable insights into overall health. In medical science, blood culture tests are used to check some types of foreign invaders that can be grown in controlled conditions. The presence of these microbes in the bloodstream can be a sign of blood infection, which is known as bacteremia. Generally, the tests comprise a simple blood sample that is analyzed in the laboratory, and medical professionals evaluate the findings to identify the origin of the infection and treatment. It is important to diagnose any blood infections because they can lead to severe complications, such as sepsis.

With the global pandemic firmly in the rearview mirror, life sciences companies are looking at key macro- and micro- economic drivers to guide their future growth. While the list of trends with wide-ranging global impact is broad, in this year, life sciences enterprises are paying particular attention to those more disruptive trends including increasing pricing pressures and changes in United States regulation, the acceleration of Generative AI (GenAI) adoption and impact, the geo-political environment, and as always, breakthrough science and outcomes. Companies are exploring how the evolution of GenAI can impact their operations and determining where to focus first and how to generate differential value. The potential of advanced technologies and these collaborations are directly integrated with life sciences companies’ overall efforts to improve patient outcomes and inform their R&D decisions.

随着现代生活节奏的加快，睡眠问题已成为全球 重点关注的健康问题之一。睡眠问题影响个人生 活质量且可能引发一系列慢性疾病，对国民健康 造成严重威胁，科技创新正为睡眠健康和慢病管 理领域带来革命性变革。随着政策支持、技术升 级和国民健康意识的提升，睡眠经济正步入快速 发展期 睡眠监测类设备是用于监测和分析个体在睡眠过 程中的生理参数和睡眠质量的设备，通过收集和 分析睡眠相关的数据，帮助用户、医生或研究人 员了解睡眠状况。随着现代医学对睡眠疾病的认 识逐渐提高，睡眠监测技术得到越来越广泛的应 用，在神经科、呼吸科、耳鼻咽喉科、口腔科、 精神科等临床科室均有开展。应用场景从院内逐 步拓展到家用场景和其他便携式场景应用 本报告将对睡眠监测类设备的定义、应用领域、 产业链、各细分领域市场状况进行分析，以期对 市场未来发展方向做出研判